Literature DB >> 16581565

Histopathologic and direct immunofluorescence findings of the papulopustular lesions in Behçet's disease.

Turna Ilknur1, Uğur Pabuççuoglu, Ciler Akin, Banu Lebe, Ali Tahsin Gunes.   

Abstract

Although papulopustular lesions are common in patients with Behçet's disease (BD), clinically they may not be differentiated from other diseases with papulopustular presentation such as acne vulgaris or folliculitis. Therefore, there is disagreement as to whether they should be used as a diagnostic criterion in BD. The aim of this study was to determine whether the histopathologic evaluation of the papulopustular lesions may assist in the diagnosis of BD. Eighteen patients with BD and 16 control patients consisting of eleven patients with bacterial folliculitis and five patients with acne vulgaris were included in the study. After the detailed histopathologic evaluation by two pathologists who were blinded to the clinical diagnoses, the histopathologic findings were classified into three patterns as follows; pattern I: vasculitis (lymphocytic or leucocytoclastic); pattern II: folliculitis and/or perifolliculitis; pattern III: superficial and/or deep perivascular, and/or interstitial dermatitis. In addition, direct immunofluorescence studies were performed in order to evaluate the deposition of IgM, IgG, IgA, C3, or fibrinogen in dermal blood vessels. 27.8% of the patients with BD (5 patients) revealed lymphocytic vasculitis, while none of the control group did; and the difference was found statistically significant (P=0.046). The rate of pattern II which included folliculitis and/or perifolliculitis was 50.0% in control patients and 16.7% in the patients with BD; and the difference was found statistically significant (P=0.038). No difference was found between the two groups with regard to pattern III or direct immunofluorescence findings (P>0.05). Our results indicate that only vasculitic changes can be useful when histopathological features of papulopustular lesions are to be employed as a diagnostic criterion in patients with suspected BD.

Entities:  

Mesh:

Year:  2006        PMID: 16581565

Source DB:  PubMed          Journal:  Eur J Dermatol        ISSN: 1167-1122            Impact factor:   3.328


  8 in total

1.  Primary localized cutaneous amyloidosis intermingled with papulopustular lesions in a patient with Behçet's disease.

Authors:  Toshiyuki Yamamoto; Yasuhiro Suzuki
Journal:  Rheumatol Int       Date:  2010-05-15       Impact factor: 2.631

Review 2.  Behçet's disease: recent advances in early diagnosis and effective treatment.

Authors:  Kenneth T Calamia; Phaedon G Kaklamanis
Journal:  Curr Rheumatol Rep       Date:  2008-10       Impact factor: 4.592

Review 3.  [Behçet's disease - ophthalmological and general aspects part I : etiology, pathogenesis and diagnostics].

Authors:  U Pleyer; D Hazirolan; S Winterhalter; N Stübiger
Journal:  Ophthalmologe       Date:  2012-11       Impact factor: 1.059

4.  Evaluation of the fungiform papillae number in Behçet's disease.

Authors:  Gökçen Akçiçek; Nihal Avcu; Serdar Uysal
Journal:  Clin Oral Investig       Date:  2014-08-06       Impact factor: 3.573

5.  Histopathological Evaluation of Behçet's Disease and Identification of New Skin Lesions.

Authors:  Ozgür Gündüz
Journal:  Patholog Res Int       Date:  2011-10-18

6.  Distinct synovial immunopathology in Behçet disease and psoriatic arthritis.

Authors:  Juan D Cañete; Raquel Celis; Troy Noordenbos; Conchita Moll; Jose A Gómez-Puerta; Pilar Pizcueta; Antonio Palacin; Paul P Tak; Raimon Sanmartí; Dominique Baeten
Journal:  Arthritis Res Ther       Date:  2009-02-06       Impact factor: 5.156

Review 7.  A New Diagnostic Way for Behcet's Disease: Skin Prick with Self-Saliva.

Authors:  Fumio Kaneko; Ari Togashi; Erika Nomura; Koichiro Nakamura
Journal:  Genet Res Int       Date:  2014-01-23

8.  Behcet's disease: systemic and ocular manifestations.

Authors:  Jelena Paovic; Predrag Paovic; Vojislav Sredovic
Journal:  Biomed Res Int       Date:  2013-10-03       Impact factor: 3.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.